Tuberculosis
📧 Sign up to get email alerts when something new happens for Tuberculosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-12-06Clinical Trial Update: Research on Key Interventional Technologies for Controlling the Epidemic in High-prevalence Areas of Tuberculosis in Guangxi, China [NA]
This clinical trial update describes a University of Toronto–sponsored interventional study in Guangxi, China, aiming to control tuberculosi…
-
CLINICAL_TRIALS trial_result · 2024-12-05Clinical Trial Update: Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment [Phase 1]
Phase 1 study evaluating absorption, elimination and safety of 14C-labeled BTZ-043, a novel tuberculosis drug. The trial has completed and r…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: Strengthening Evidence on Optimal Multidrug-resistant Tuberculosis Treatment Regimens
Clinical trial update highlighting efforts to strengthen evidence for optimal multidrug-resistant tuberculosis regimens, including considera…
-
CLINICAL_TRIALS research · 2024-12-05Clinical Trial Update: DeMONSTRATE-TB Study in Ethiopia [Phase 2, Phase 3]
The DeMONSTRATE-TB study is a Phase 2/3 clinical trial being conducted in Ethiopia to evaluate strategies aimed at reducing tuberculosis inc…
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: A Systemic Screening for TB Disease in High-risk Groups in Barcelona
A clinical trial in Barcelona is testing systemic screening for tuberculosis disease in high-risk groups. The study is currently recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-11-29Clinical Trial Update: Immunocompetent Versus Immunocompromised Tuberculosis (TB) Patients
A clinical trial will compare outcomes in immunocompetent versus immunocompromised tuberculosis patients and is currently not yet recruiting…
-
CLINICAL_TRIALS trial_result · 2024-11-27Clinical Trial Update: Evaluating the Potential of Large Language Models for Respiratory Disease Consultations [NA]
This completed clinical trial evaluated the potential of large language models to assist respiratory disease consultations. It covered multi…
-
CLINICAL_TRIALS trial_result · 2024-11-25Clinical Trial Update: Adequacy of the New Pediatric Isoniazid/Rifampin/Pyrazinamide (HRZ) Tablet
This clinical trial update reports on the adequacy of a new pediatric HRZ tablet (isoniazid/rifampin/pyrazinamide) for treating tuberculosis…
-
FDA approval · 2024-11-22FDA Approved: PRETOMANID — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Pretomanid submitted by Viatris Specialty LLC, updating its labeling to reflect its use in drug-…
-
FDA approval · 2024-11-22FDA Approved: ISONIAZID — Supplemental Application (Chartwell RX, LLC)
The FDA approved a supplemental application for the generic drug isoniazid submitted by Chartwell RX, LLC.
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Pharmacokinetic Study of Sudapyridine（WX-081）in Healthy Chinese Subjects [Phase 1]
This is a Phase 1 pharmacokinetic study of sudapyridine (WX-081) in healthy Chinese subjects to characterize its PK profile for tuberculosis…
-
CLINICAL_TRIALS research · 2024-11-22Clinical Trial Update: Evaluation of IGRA, Symptoms and Chest Radiograph for Subclinical TB Detection in ESRD and KT
A recruiting clinical trial evaluating IGRA testing, symptom assessment, and chest radiography for detecting subclinical tuberculosis in pat…
-
CLINICAL_TRIALS other · 2024-11-22Clinical Trial Update: Multidrug Resistance in Newly Diagnosed TB Patient
This clinical trial update from Assiut University concerns multidrug resistance in newly diagnosed tuberculosis patients and shows the study…
-
CLINICAL_TRIALS research · 2024-11-05Clinical Trial Update: Evaluation of Different Diagnostic Methods of Tuberculosis in Assiut University Hospitals
A clinical trial update from Assiut University Hospitals evaluating different diagnostic methods for tuberculosis, with the study currently …
-
FDA approval · 2024-10-24FDA Approved: ISONIAZID — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for isoniazid submitted by Teva Pharmaceuticals USA, Inc. (ANDA 080937).
-
FDA approval · 2024-10-24FDA Approved: ISONIAZID — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for isoniazid from Teva Pharmaceuticals USA, Inc., confirming regulatory clearance for this gene…
-
CLINICAL_TRIALS trial_result · 2024-10-23Clinical Trial Update: Using SMS Reminders, Phone Calls and Money Incentives to Enhance Linkage to Care of Presumptive TB Patients in Uganda [NA]
A completed Makerere University study in Uganda evaluated SMS reminders, phone calls, and financial incentives to improve linkage to care am…
-
CLINICAL_TRIALS trial_result · 2024-10-16Clinical Trial Update: Whole Genome Sequencing of Tuberculosis for Disease Control in Madagascar [NA]
This completed trial investigates whole genome sequencing of Mycobacterium tuberculosis to inform tuberculosis control efforts in Madagascar…
-
CLINICAL_TRIALS trial_result · 2024-10-10Clinical Trial Update: Potential Role of Microbiome in Tuberculosis
A clinical trial investigating the potential role of the microbiome in tuberculosis has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-08Clinical Trial Update: A Phase 1, Drug-Drug Interaction Study of TBAJ-876 in Healthy Adults [Phase 1]
Phase 1 study assessing drug-drug interaction of TB antibiotic candidate TBAJ-876 in healthy adults has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-10-03Clinical Trial Update: Integrated Discovery and Development of Innovative TB Diagnostics
A Harvard-led clinical trial evaluating innovative diagnostics for pulmonary tuberculosis has completed, marking a registry status update.
-
CLINICAL_TRIALS research · 2024-10-02Clinical Trial Update: Efficacy, Safety and Pharmacokinetics of DTG with RIF [Phase 2]
This Phase 2 trial is evaluating the efficacy, safety, and pharmacokinetics of dolutegravir with rifampin in people with HIV/TB coinfection …
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: TB-CAPT MTB/XDR Study
Clinical trial update for the TB-CAPT MTB/XDR study. The current status is Active Not Recruiting and the sponsor is the Foundation for Innov…
-
CLINICAL_TRIALS research · 2024-10-01Clinical Trial Update: Safety of Administering Isoniazid to SLE Patients to Prevent TB [Phase 2, Phase 3]
A clinical trial update evaluating the safety of administering isoniazid to patients with systemic lupus erythematosus to prevent tuberculos…
-
CLINICAL_TRIALS trial_result · 2024-09-26Clinical Trial Update: Six-months Versus Nine-months ATT for Ocular TB [Phase 4]
Completed Phase 4 trial comparing six-month versus nine-month anti-tuberculosis therapy durations for ocular tuberculosis, evaluating condit…